Literature DB >> 12481297

Podocyte-specific expression of cre recombinase in transgenic mice.

Marcus J Moeller1, Silja K Sanden, Abdulsalam Soofi, Roger C Wiggins, Lawrence B Holzman.   

Abstract

We report a transgenic mouse line that expresses Cre recombinase exclusively in podocytes. Twenty- four transgenic founders were generated in which Cre recombinase was placed under the regulation of a 2.5-kb fragment of the human NPHS2 promoter. Previously, this fragment was shown to drive beta-galactosidase (beta-gal) expression exclusively in podocytes of transgenic mice. For analysis, founder mice were bred with ROSA26 mice, a reporter line that expresses beta-gal in cells that undergo Cre recombination. Eight of 24 founder lines were found to express beta-gal exclusively in the kidney. Histological analysis of the kidneys showed that beta-gal expression was confined to podocytes. Cre recombination occurred during the capillary loop stage in glomerular development. No evidence for Cre recombination was detected in any of 14 other tissues examined. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12481297     DOI: 10.1002/gene.10164

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  164 in total

1.  DNA Methyltransferase 1 Controls Nephron Progenitor Cell Renewal and Differentiation.

Authors:  Nicola Wanner; Julia Vornweg; Alexander Combes; Sean Wilson; Julia Plappert; Gesa Rafflenbeul; Victor G Puelles; Raza-Ur Rahman; Timur Liwinski; Saskia Lindner; Florian Grahammer; Oliver Kretz; Mary E Wlodek; Tania Romano; Karen M Moritz; Melanie Boerries; Hauke Busch; Stefan Bonn; Melissa H Little; Wibke Bechtel-Walz; Tobias B Huber
Journal:  J Am Soc Nephrol       Date:  2018-12-05       Impact factor: 10.121

Review 2.  Use of knock-out mouse models for the study of renal ion channels.

Authors:  H Barrière; M Tauc; P Poujeol
Journal:  J Membr Biol       Date:  2004-04-01       Impact factor: 1.843

3.  Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria.

Authors:  Chunsun Dai; Moin A Saleem; Lawrence B Holzman; Peter Mathieson; Youhua Liu
Journal:  Kidney Int       Date:  2010-03-10       Impact factor: 10.612

4.  Tamoxifen-inducible podocyte-specific iCre recombinase transgenic mouse provides a simple approach for modulation of podocytes in vivo.

Authors:  Jinrong Wang; Yin Wang; Jianyin Long; Benny H J Chang; Mathew H Wilson; Paul Overbeek; Farhad R Danesh
Journal:  Genesis       Date:  2010-07       Impact factor: 2.487

5.  Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease.

Authors:  Sanja Sever; Mehmet M Altintas; Sharif R Nankoe; Clemens C Möller; David Ko; Changli Wei; Joel Henderson; Elizabetta C del Re; Lianne Hsing; Ann Erickson; Clemens D Cohen; Matthias Kretzler; Dontscho Kerjaschki; Alexander Rudensky; Boris Nikolic; Jochen Reiser
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

6.  The Role of Palladin in Podocytes.

Authors:  Nadine Artelt; Tim A Ludwig; Henrik Rogge; Panagiotis Kavvadas; Florian Siegerist; Antje Blumenthal; Jens van den Brandt; Carol A Otey; Marie-Louise Bang; Kerstin Amann; Christos E Chadjichristos; Christos Chatziantoniou; Karlhans Endlich; Nicole Endlich
Journal:  J Am Soc Nephrol       Date:  2018-05-02       Impact factor: 10.121

7.  Unexpected kidney-restricted role for IL-17 receptor signaling in defense against systemic Candida albicans infection.

Authors:  Kritika Ramani; Chetan V Jawale; Akash H Verma; Bianca M Coleman; Jay K Kolls; Partha S Biswas
Journal:  JCI Insight       Date:  2018-05-03

8.  KLF4-dependent epigenetic remodeling modulates podocyte phenotypes and attenuates proteinuria.

Authors:  Kaori Hayashi; Hiroyuki Sasamura; Mari Nakamura; Tatsuhiko Azegami; Hideyo Oguchi; Yusuke Sakamaki; Hiroshi Itoh
Journal:  J Clin Invest       Date:  2014-05-08       Impact factor: 14.808

9.  Def-6, a novel regulator of small GTPases in podocytes, acts downstream of atypical protein kinase C (aPKC) λ/ι.

Authors:  Kirstin Worthmann; Michael Leitges; Beina Teng; Marcello Sestu; Irini Tossidou; Thomas Samson; Hermann Haller; Tobias B Huber; Mario Schiffer
Journal:  Am J Pathol       Date:  2013-10-03       Impact factor: 4.307

10.  Glomerular filtration is normal in the absence of both agrin and perlecan-heparan sulfate from the glomerular basement membrane.

Authors:  Seth Goldberg; Scott J Harvey; Jeanette Cunningham; Karl Tryggvason; Jeffrey H Miner
Journal:  Nephrol Dial Transplant       Date:  2009-01-14       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.